Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports.
Make a selection below to explore our full database of 4 results matching: "H Hagino"
ACE Reports
(4 Reports)
ACE Reports
Our AI driven High Impact metric predicts an article's future number of citations by considering the content of the article.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Open Advanced Search
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Trauma
Effect of coordinator-based osteoporosis intervention on quality of life in patients with fragility fractures: a prospective randomized trial
Osteoporos Int. 2022 01-Jul;():. 10.1007/s00198-021-06279-6
Effect of coordinator-based osteoporosis intervention on quality of life in patients with fragility fractures: a prospective randomized trial
Osteoporos Int. 2022 01-Jul;():. 10.1007/s00198-021-06279-6
General Orthopaedics
Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial
Osteoporos Int. 2021 01-Mar;():. 10.1007/s00198-021-05825-6
Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial
Osteoporos Int. 2021 01-Mar;():. 10.1007/s00198-021-05825-6
General Orthopaedics
Efficacy, tolerability and safety of once-monthly administration of 75 mg risedronate in Japanese patients with involutional osteoporosis: A comparison with a 2.5 mg once-daily dosage regimen
Bone. 2014 Feb;59:44-52. doi: 10.1016/j.bone.2013.10.017. Epub 2013 Oct 29.
Efficacy, tolerability and safety of once-monthly administration of 75 mg risedronate in Japanese patients with involutional osteoporosis: A comparison with a 2.5 mg once-daily dosage regimen
This report has been verified by one or more authors of the original publication.
Bone. 2014 Feb;59:44-52. doi: 10.1016/j.bone.2013.10.017. Epub 2013 Oct 29.
Metabolic Disorders
Once-weekly teriparatide reduces vertebral fracture risk: Subgroup analysis from the Teriparatide Once Weekly Efficacy Research (TOWER) trial
Once-weekly teriparatide reduces vertebral fracture risk: Subgroup analysis from the Teriparatide Once Weekly Efficacy Research (TOWER) trial